Monitoring serum and urine osteoprotegrin levens during the treatment of patients with multiple myeloma.

被引：0
|
作者：
Moreb, JS [1 ]
Zucali, JR [1 ]
Roberts, C [1 ]
机构：
[1] Univ Florida, Shands Hosp, Stem Cell Lab, Gainesville, FL 32611 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5223
引用
收藏
页码：374B / 374B
页数：1
相关论文
共 50 条
  • [31] CZDez: An oral chemotherapeutic regimen for the treatment of multiple myeloma.
    Moreton, P
    Morgan, GJ
    Cooke, G
    Hillmen, P
    Child, T
    BLOOD, 2001, 98 (11) : 310B - 310B
  • [32] A novel candidate for immunologic target in treatment of multiple myeloma.
    Matsushita, Maiko
    Saito, Saku
    Mori, Kanae
    Yokoe, Shinya
    Ichikawa, Daiju
    Hattori, Yutaka
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 122 - 122
  • [33] Development of serum free light chain immunoassays for the detection and monitoring of patients with Bence Jones Myeloma.
    Smith, L
    Mead, GP
    Carr-Smith, HD
    Drayson, MT
    Bradwell, AR
    CLINICAL CHEMISTRY, 2001, 47 (06) : A43 - A43
  • [34] Retrospective analysis of second malignancies in patients with multiple myeloma.
    Talamo, Giampaolo
    Ehmann, W. Christopher
    Dolloff, Nathan G.
    Malysz, Jozef
    Drabick, Joseph J.
    Rybka, Witold B.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [35] Utility of bortezornib retreatment for patients with relapsed multiple myeloma.
    Wolf, Jeffrey Lee
    Richardson, Paul
    Schuster, Michael
    LeBlanc, Annette
    Battleman, David
    Walters, Ian
    BLOOD, 2006, 108 (11) : 1008A - 1008A
  • [36] Tracking dendritic cells in vivo in patients with multiple myeloma.
    Wall, DM
    Thompson, M
    Mileshkin, L
    Loveland, B
    Coverdale, J
    Xing, PX
    Bartholeyns, J
    Hicks, R
    Prince, M
    BLOOD, 2005, 106 (11) : 968A - 968A
  • [37] Initial studies of monocyte function in patients with multiple myeloma.
    Mainwaring, CJ
    Williams, M
    Singer, CRJ
    Smith, JG
    Prentice, AG
    Johnson, S
    Bell, A
    Kruger, A
    Gutteridge, C
    Mills, M
    Rhodes, E
    Kelsey, S
    BLOOD, 1995, 86 (10) : 3339 - 3339
  • [38] Bone mineral density (BMD) in patients with multiple myeloma.
    Hungria, VTM
    Gouveia, CHA
    Malvestiti, LF
    Bianco, AC
    Barros, JC
    Chiattone, CS
    Marone, MMS
    BLOOD, 1995, 86 (10) : 3328 - 3328
  • [39] Monocytic function is abnormal in some patients with multiple myeloma.
    Mainwaring, CJ
    Williams, MA
    Singer, CRJ
    Lush, RJ
    Smith, JG
    Prentice, AG
    Johnson, S
    Bell, A
    Kruger, A
    Gutteridge, C
    Mills, M
    Rhodes, E
    Kelsey, S
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 306 - 306
  • [40] MGUS: Comparison of patients who converted to multiple myeloma.
    Stanisic, S
    Saluan, MA
    McLain, D
    Cakulev, I
    Rybicki, L
    Hussein, MA
    BLOOD, 1998, 92 (10) : 271B - 271B
12345